Amino-Terminal Pro-B-Type Natriuretic Peptide: Analytic Considerations

American Journal of Cardiology

Volumn 101, Issue 3 SUPPL., 2008, Pages

  Ordonez Llanos, Jordi ^a   Collinson, Paul O ^b   Christenson, Robert H ^c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART FAILURE; HUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; IMMUNOASSAY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 38649091358     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.013     Document Type: Article

References (34)

1. Tang W.H., Francis G.S., Morrow D.A., Newby L.K., Cannon C.P., Jesse R.L., Storrow A.B., Christenson R.H., Apple F.S., Ravkilde J., and Wu A.H. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation 116 (2007) e99-e109
2. Apple F.S., Wu A.H., Jaffe A.S., Panteghini M., Christenson R.H., Cannon C.P., Francis G., Jesse R.L., Morrow D.A., Newby L.K., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation 116 (2007) e95-e98
3. Lippi G., Guidi G.C., Mattiuzzi C., and Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 44 (2006) 358-365
4. Ala-Kopsala M., Magga J., Peuhkurinen K., Leipala J., Ruskoaho H., Leppaluoto J., and Vuolteenaho O. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50 (2004) 1576-1588
5. Chenevier-Gobeaux C., Guillot D., Ursulet J., Paul J.L., Ekindjian O.G., Desmoulins D., and Benoit M.O. The N-terminal pro-brain natriuretic peptide (NT-proBNP) assay with the Stratus CS analyzer. [in French]. Ann Biol Clin (Paris) 65 (2007) 77-82
6. Zugck C., Nelles M., Katus H.A., Collinson P.O., Gaze D.C., Dikkeschei B., Gurr E., Hayen W., Haass M., Hechler C., et al. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood. Clin Chem Lab Med 44 (2006) 1269-1277
7. Kjaer A., Appel J., Hildebrandt P., and Petersen C.L. Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects. Eur J Heart Fail 6 (2004) 29-39
8. Scharhag J., Herrmann M., Urhausen A., Haschke M., Herrmann W., and Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 150 (2005) 1128-1134
9. Sokoll L.J., Baum H., Collinson P.O., Gurr E., Haass M., Luthe H., Morton J.J., Nowatzke W., and Zingler C. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 42 (2004) 965-972
10. Boomsma F., Deinum J., and van den Meiracker A.H. Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. Clin Chem 47 (2001) 963-965
11. Bruins S., Fokkema M.R., Romer J.W., Dejongste M.J., van der Dijs F.P., van den Ouweland J.M., and Muskiet F.A. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50 (2004) 2052-2058
12. Yeo K.T., Wu A.H., Apple F.S., Kroll M.H., Christenson R.H., Lewandrowski K.B., Sedor F.A., and Butch A.W. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 (2003) 107-115
13. Barnes S.C., Collinson P.O., Galasko G., Lahiri A., and Senior R. Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers. Ann Clin Biochem 41 (2004) 459-463
14. Christenson R.H., Azzazy H.M., and Duh S.H. Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems. Clin Chim Acta 384 (2007) 176-178
15. Mueller T., Gegenhuber A., Dieplinger B., Poelz W., and Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 42 (2004) 942-944
16. Ng L.L., Loke I.W., Davies J.E., Geeranavar S., Khunti K., Stone M.A., Chin D.T., and Squire I.B. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol 45 (2005) 1043-1050
17. Apple F.S., Panteghini M., Ravkilde J., Mair J., Wu A.H., Tate J., Pagani F., Christenson R.H., and Jaffe A.S. Quality specifications for B-type natriuretic peptide assays. Clin Chem 51 (2005) 486-493
18. Di Serio F., Ruggieri V., Varraso L., De Sario R., Mastrorilli A., and Pansini N. Analytical evaluation of the Dade Behring Dimension RxL automated N-terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. Clin Chem Lab Med 43 (2005) 1263-1273
19. Hawkridge A.M., Heublein D.M., Bergen III H.R., Cataliotti A., Burnett Jr. J.C., and Muddiman D.C. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci U S A 102 (2005) 17442-17447
20. Lam C.S., Burnett Jr. J.C., Costello-Boerrigter L., Rodeheffer R.J., and Redfield M.M. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 49 (2007) 1193-1202
21. Seidler T., Pemberton C., Yandle T., Espiner E., Nicholls G., and Richards M. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 255 (1999) 495-501
22. Giuliani I., Rieunier F., Larue C., Delagneau J.F., Granier C., Pau B., Ferriere M., Saussine M., Cristol J.P., Dupuy A.M., et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52 (2006) 1054-1061
23. Liang F., O'Rear J., Schellenberger U., Tai L., Lasecki M., Schreiner G.F., Apple F.S., Maisel A.S., Pollitt N.S., and Protter A.A. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 49 (2007) 1071-1078
24. Rawlins M.L., Owen W.E., and Roberts W.L. Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 123 (2005) 439-445
25. Coste J., Jourdain P., and Pouchot J. A gray zone assigned to inconclusive results of quantitative diagnostic tests: application to the use of brain natriuretic peptide for diagnosis of heart failure in acute dyspneic patients. Clin Chem 52 (2006) 2229-2235
26. Johnston N., Jernberg T., Lindahl B., Lindback J., Stridsberg M., Larsson A., Venge P., and Wallentin L. Biochemical indicators of cardiac and renal function in a healthy elderly population. Clin Biochem 37 (2004) 210-216
27. Galasko G.I., Lahiri A., Barnes S.C., Collinson P., and Senior R. What is the normal range for N-terminal pro-brain natriuretic peptide?. How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 (2005) 2269-2276
28. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., and Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
29. Krauser D.G., Chen A.A., Tung R., Anwaruddin S., Baggish A.L., and Januzzi Jr. J.L. Neither race nor gender influences the usefulness of amino-terminal pro-brain natriuretic peptide testing in dyspneic subjects: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. J Card Fail 12 (2006) 452-457
30. Januzzi Jr. J.L., Chen-Tournoux A.A., and Moe G. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol 101 (2008) 29A-38A
31. Cameron S.J., Green G.B., White C.N., Laterza O.F., Clarke W., Kim H., and Sokoll L.J. Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromes. Clin Biochem 39 (2006) 11-18
32. Wu A.H. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 152 (2006) 828-834
33. Schou M., Gustafsson F., Kjaer A., and Hildebrandt P.R. Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J 28 (2007) 177-182
34. Araujo J.P., Azevedo A., Lourenco P., Rocha-Goncalves F., Ferreira A., and Bettencourt P. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure. Am J Cardiol 98 (2006) 1248-1250